Active management of third stage of labor

Effect of intraumbilical oxytocin on the third stage of labor: A randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201206182204N3

Enrollment

Registered

2012-06-23

Start date

2011-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Third-stage haemorrhage. Haemorrhage associated with retained, trapped or adherent placenta

Interventions

Intervention 1: injetion of 20 units of diluted oxytocin in the umbilical vein+infusuion of 1000 CC of ringer serum in case group. Intervention 2: Infusuion of 1000 CC of ringer serum in control grou

Prevention

injetion of 20 units of diluted oxytocin in the umbilical vein+infusuion of 1000 CC of ringer serum in case group

Infusuion of 1000 CC of ringer serum in control group

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Including criteria: 18 to 35 years old primiparous women; Normal pregnancy; single fetus; Gestational age of 37 to 42 weeks; cephalic presentation; having a normal vaginal delivery;-baby weight of 2500 to 4500 grams Excluding criteria: fundal pressure; labor induction or stimulation via oxytocin

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration of third stage of labor. Timepoint: after placenta delivery. Method of measurement: observation.	—

Secondary

Measure	Time frame
Hemoglobin level. Timepoint: 24 hours after birth. Method of measurement: CBC test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShirin Zargar Shoushtari

Jundishapour Ahvaz University of Medical Sciences

shri_zar@yahoo.com+98 611367547

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026